Randomised clinical trial: The effects of Helicobacter pylori eradication on glandular atrophy and intestinal metaplasia after subtotal gastrectomy for gastric cancer

Alimentary Pharmacology and Therapeutics

Volumn 38, Issue 5, 2013, Pages 477-489

  Cho, S J ^a   Choi, I J ^a   Kook, M C ^a   Yoon, H ^a   Park, S ^a,b   Kim, C G ^a   Lee, J Y ^a   Lee, J H ^a   Ryu, K W ^a   Kim, Y W ^a  

^a National Cancer Center   (South Korea)

^b Yonsei University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; PLACEBO; RABEPRAZOLE;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; BACTERIAL CLEARANCE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG RESPONSE; ERADICATION THERAPY; FEMALE; FOLLOW UP; GASTRECTOMY; HELICOBACTER INFECTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STOMACH ATROPHY; STOMACH CANCER; STOMACH GLAND; TREATMENT OUTCOME;

EID: 84882455375     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.12402     Document Type: Article

References (51)

1. Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7-14 June 1994. IARC Monogr Eval Carcinog Risks Hum 1994; 61: 1-241.
2. You WC, Zhang L, Gail MH, et al,. Gastric dysplasia and gastric cancer: Helicobacter pylori, serum vitamin C, and other risk factors. J Natl Cancer Inst 2000; 92: 1607-12.
3. Uemura N, Okamoto S, Yamamoto S, et al,. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001; 345: 784-9.
4. Cho SJ, Choi IJ, Kim CG, et al,. Helicobacter pylori seropositivity is associated with gastric cancer regardless of tumor subtype in Korea. Gut Liver 2010; 4: 466-74.
5. Shin A, Kim J, Park S,. Gastric cancer epidemiology in Korea. J Gastric Cancer 2011; 11: 135-40.
6. Fock KM, Talley N, Moayyedi P, et al,. Asia-Pacific consensus guidelines on gastric cancer prevention. J Gastroenterol Hepatol 2008; 23: 351-65.
7. Malfertheiner P, Megraud F, O'Morain CA, et al,. Management of Helicobacter pylori infection-The Maastricht IV/Florence Consensus Report. Gut 2012; 61: 646-64.
8. Fukase K, Kato M, Kikuchi S, et al,. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet 2008; 372: 392-7.
9. Lee JY, Choi IJ, Cho SJ, et al,. Endoscopic submucosal dissection for metachronous tumor in the remnant stomach after distal gastrectomy. Surg Endosc 2010; 24: 1360-6.
10. Nozaki I, Nasu J, Kubo Y, Tanada M, Nishimura R, Kurita A,. Risk factors for metachronous gastric cancer in the remnant stomach after early cancer surgery. World J Surg 2010; 34: 1548-54.
11. Sung JJ, Lin SR, Ching JY, et al,. Atrophy and intestinal metaplasia one year after cure of H. pylori infection: a prospective, randomized study. Gastroenterology 2000; 119: 7-14.
12. Rokkas T, Pistiolas D, Sechopoulos P, Robotis I, Margantinis G,. The long-term impact of Helicobacter pylori eradication on gastric histology: a systematic review and meta-Analysis. Helicobacter 2007; 12 (Suppl 2): 32-8.
13. Correa P, Fontham ET, Bravo JC, et al,. Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-helicobacter pylori therapy. J Natl Cancer Inst 2000; 92: 1881-8.
14. You WC, Brown LM, Zhang L, et al,. Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions. J Natl Cancer Inst 2006; 98: 974-83.
15. Bechi P, Amorosi A, Mazzanti R, Romagnoli P, Tonelli L,. Gastric histology and fasting bile reflux after partial gastrectomy. Gastroenterology 1987; 93: 335-43.
16. O'Connor HJ, Dixon MF, Wyatt JI, et al,. Effect of duodenal ulcer surgery and enterogastric reflux on Campylobacter pyloridis. Lancet 1986; 2: 1178-81.
17. Dixon MF, Mapstone NP, Neville PM, Moayyedi P, Axon AT,. Bile reflux gastritis and intestinal metaplasia at the cardia. Gut 2002; 51: 351-5.
18. Howden CW, Hunt RH,. Relationship between gastric secretion and infection. Gut 1987; 28: 96-107.
19. Fried M, Siegrist H, Frei R, et al,. Duodenal bacterial overgrowth during treatment in outpatients with omeprazole. Gut 1994; 35: 23-6.
20. Sobin LH, Wittekind C,. TNM classification of malignant tumors. 6th ed. New York: Wiley-Liss, 2002.
21. Dixon MF, Genta RM, Yardley JH, Correa P,. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996; 20: 1161-81.
22. Said RM, Cheah PL, Chin SC, Goh KL,. Evaluation of a new biopsy urease test: Pronto Dry, for the diagnosis of Helicobacter pylori infection. Eur J Gastroenterol Hepatol 2004; 16: 195-9.
23. Rugge M, Correa P, Dixon MF, et al,. Gastric mucosal atrophy: interobserver consistency using new criteria for classification and grading. Aliment Pharmacol Ther 2002; 16: 1249-59.
24. Rugge M, Genta RM,. Staging gastritis: an international proposal. Gastroenterology 2005; 129: 1807-8.
25. Rugge M, Meggio A, Pennelli G, et al,. Gastritis staging in clinical practice: the OLGA staging system. Gut 2007; 56: 631-6.
26. Satoh K, Osawa H, Yoshizawa M, et al,. Assessment of atrophic gastritis using the OLGA system. Helicobacter 2008; 13: 225-9.
27. Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer 2011; 14: 113-23.
28. Kubo M, Sasako M, Gotoda T, et al,. Endoscopic evaluation of the remnant stomach after gastrectomy: proposal for a new classification. Gastric Cancer 2002; 5: 83-9.
29. Ohkusa T, Fujiki K, Takashimizu I, et al,. Improvement in atrophic gastritis and intestinal metaplasia in patients in whom Helicobacter pylori was eradicated. Ann Intern Med 2001; 134: 380-6.
30. Scharf O, Colevas AD,. Adverse event reporting in publications compared with sponsor database for cancer clinical trials. J Clin Oncol 2006; 24: 3933-8.
31. Mera R, Fontham ET, Bravo LE, et al,. Long term follow up of patients treated for Helicobacter pylori infection. Gut 2005; 54: 1536-40.
32. Kim CG, Choi IJ, Lee JY, et al,. Biopsy site for detecting Helicobacter pylori infection in patients with gastric cancer. J Gastroenterol Hepatol 2009; 24: 469-74.
33. Lee JH, Park YS, Choi KS, et al,. Optimal biopsy site for Helicobacter pylori detection during endoscopic mucosectomy in patients with extensive gastric atrophy. Helicobacter 2012; 17: 405-10.
34. Ritchie WP,. Alkaline reflux gastritis: a critical reappraisal. Gut 1984; 25: 975-87.
35. Nagahata Y, Kawakita N, Azumi Y, Numata N, Yano M, Saitoh Y,. Etiological involvement of Helicobacter pylori in "reflux" gastritis after gastrectomy. Am J Gastroenterol 1996; 91: 2130-4.
36. Fukuhara K, Osugi H, Takada N, et al,. Duodenogastric reflux eradicates Helicobacter pylori after distal gastrectomy. Hepatogastroenterology 2004; 51: 1548-50.
37. Danesh J, Appleby P, Peto R,. How often does surgery for peptic ulceration eradicate Helicobacter pylori? Systematic review of 36 studies. BMJ 1998; 316: 746-7.
38. Bair MJ, Wu MS, Chang WH, et al,. Spontaneous clearance of Helicobacter pylori colonization in patients with partial gastrectomy: correlates with operative procedures and duration after operation. J Formos Med Assoc 2009; 108: 13-9.
39. Miwa K, Hattori T, Miyazaki I,. Duodenogastric reflux and foregut carcinogenesis. Cancer 1995; 75 (6 Suppl): 1426-32.
40. Chung JW, Lee GH, Han JH, et al,. The trends of one-week first-line and second-line eradication therapy for Helicobacter pylori infection in Korea. Hepatogastroenterology 2011; 58: 246-50.
41. Kim MS, Kim N, Kim SE, et al,. Long-term Follow-up Helicobacter pylori Reinfection Rate and Its Associated Factors in Korea. Helicobacter 2013; 18: 135-42.
42. Wong BC, Lam SK, Wong WM, et al,. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA 2004; 291: 187-94.
43. Maehata Y, Nakamura S, Fujisawa K, et al,. Long-term effect of Helicobacter pylori eradication on the development of metachronous gastric cancer after endoscopic resection of early gastric cancer. Gastrointest Endosc 2012; 75: 39-46.
44. Malfertheiner P, Megraud F, O'Morain C, et al,. Current concepts in the management of Helicobacter pylori infection-The Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther 2002; 16: 167-80.
45. Lam SK, Talley NJ,. Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection. J Gastroenterol Hepatol 1998; 13: 1-12.
46. Uemura N, Mukai T, Okamoto S, et al,. Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer. Cancer Epidemiol Biomarkers Prev 1997; 6: 639-42.
47. Chey WD, Wong BC,. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am J Gastroenterol 2007; 102: 1808-25.
48. Kim N, Kim JJ, Choe YH, Kim HS, Kim JI, Chung IS,. Diagnosis and treatment guidelines for Helicobacter pylori infection in Korea. Korean J Gastroenterol 2009; 54: 269-78.
49. Malfertheiner P, Megraud F, O'Morain C, et al,. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 2007; 56: 772-81.
50. Meimarakis G, Winter H, Assmann I, et al,. Helicobacter pylori as a prognostic indicator after curative resection of gastric carcinoma: a prospective study. Lancet Oncol 2006; 7: 211-22.
51. Marrelli D, Pedrazzani C, Berardi A, et al,. Negative Helicobacter pylori status is associated with poor prognosis in patients with gastric cancer. Cancer 2009; 115: 2071-80.